F. Hoffmann-La Roche Ltd, Pfizer Inc., Astellas Pharma Inc., and Sun Pharmaceutical Industries Limited, among others, are the major players in the global bullous pemphigoid treatment market.
The global bullous pemphigoid treatment market is driven by the rising skin disease treatment market, which attained a value of USD 19 billion in 2020. In the forecast period of 2022-2027, the skin disease treatment market is expected to grow at a CAGR of 3%.
The globally increasing geriatric population has led to the heightened rate of occurrence of the disease, which has bolstered the market growth. The increasing awareness programmes by healthcare institutions and NGOs has also led to significant market growth globally. The affordable and commonly available medicine used in the treatment of the disease helps in the growth as well.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The European region is significant in the treatment of this disease due to their easy accessibility of healthcare facilities. North America also has a significant number of healthcare facilities and treatment centres for the disease, contributing immensely to the market growth. Massive improvements in technology and reimbursement policies in these regions help in the growth of the market. Due to improved medical facilities and rising awareness, the Asia Pacific and Middle East areas are predicted to rise significantly during the forecast period.
Headquarters: Basel, Switzerland
F. Hoffmann-La Roche AG is a leading multinational healthcare company and has two divisions, namely, pharmaceuticals, and diagnostics. It is the largest pharmaceutical company in the world and a leader in the treatment of cancer. The company also deals with prevention diagnosis and helps save lives of millions of patients globally. The company has been active in the discovery, development, manufacture, and marketing of healthcare solutions for over 100 years.
Headquarters: New York, United States
Pfizer is a pharmaceutical and biotechnology corporation. The company deals with the production and development of vaccines and medicines for oncology, cardiology, neurology, immunology, and endocrinology. This company has also produced vaccines for the current COVID-19 pandemic and is saving lives globally.
Headquarters: Tokyo, Japan
Astellas Pharma is a globally renowned pharmaceutical research company. They work on the innovation of new drugs and medical solutions and aim to improve the health of the society through their reliable pharmaceutical products. Astellas is committed to turning innovative science into medical solutions that bring value and hope to patients and their families.
Headquarters: Mumbai, India
Sun Pharma is India’s largest generic pharmaceutical company. The company provides high quality medicines in over 100 countries, with over 40 manufacturing facilities across 5 continents. The company also invests significantly in research and development and has its own R&D centres worldwide. Sun Pharma has around 2,000 scientists and R&D investments of over 7-8% of annual revenues.
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.